Cargando…
hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease. The association between epithelial-mesenchymal transition (EMT) and fibrosis is quite ascertained, but its link to eventual tubule dysfunction is missing. Here, we show that human microRNA- (hsa-miR-) 199b-3p protects renal t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257373/ https://www.ncbi.nlm.nih.gov/pubmed/34257820 http://dx.doi.org/10.1155/2021/8814163 |
_version_ | 1783718299501068288 |
---|---|
author | Bai, Shoujun Xiong, Xiaoyan Tang, Bo Ji, Tingting Li, Xiaoying Qu, Xiaolei Li, Weiliang |
author_facet | Bai, Shoujun Xiong, Xiaoyan Tang, Bo Ji, Tingting Li, Xiaoying Qu, Xiaolei Li, Weiliang |
author_sort | Bai, Shoujun |
collection | PubMed |
description | Diabetic nephropathy (DN) is the leading cause of end-stage renal disease. The association between epithelial-mesenchymal transition (EMT) and fibrosis is quite ascertained, but its link to eventual tubule dysfunction is missing. Here, we show that human microRNA- (hsa-miR-) 199b-3p protects renal tubules from diabetic-induced injury by repressing KDM6A, a histone lysine demethylase regulating E-cadherin expression. Lower E-cadherin expression is related to a higher level of KDM6A, while E-cadherin is promoted upon treatment with the KDM6A inhibitor GSK-J4 in both high glucose- (HG-) induced HK2 cells and the kidneys from streptozotocin- (STZ-) induced type 1 diabetic mice. However, overexpression or RNA silencing of E-cadherin fails to alter KDM6A expression. We also show that the upregulation of KDM6A is associated with the increased methylation level of the E-cadherin promoter. Then, the target prediction results and a dual-luciferase assay show that hsa-miR-199b-3p is a new miRNA that targets KDM6A. Overexpression of hsa-miR-199b-3p increases E-cadherin expression and prevents EMT through repressing KDM6A expression in HG-induced HK2 cells. In contrast, inhibitor-induced hsa-miR-199b-3p knockdown has opposite effects, as it decreases E-cadherin level and worsens EMT, accompanied by increased levels of KDM6A. Besides, Mir199b-knockout mice without mmu-miR-119b-3p expression exhibit more renal tubule dysfunction and more serious kidney tissue damage upon treatment with STZ. These results demonstrate that hsa-miR-199b-3p improves E-cadherin expression and prevents the progression of DN through targeting KDM6A. miR-199b-3p could be a future biomarker or target for the diagnosis or treatment of DN. |
format | Online Article Text |
id | pubmed-8257373 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-82573732021-07-12 hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy Bai, Shoujun Xiong, Xiaoyan Tang, Bo Ji, Tingting Li, Xiaoying Qu, Xiaolei Li, Weiliang Oxid Med Cell Longev Research Article Diabetic nephropathy (DN) is the leading cause of end-stage renal disease. The association between epithelial-mesenchymal transition (EMT) and fibrosis is quite ascertained, but its link to eventual tubule dysfunction is missing. Here, we show that human microRNA- (hsa-miR-) 199b-3p protects renal tubules from diabetic-induced injury by repressing KDM6A, a histone lysine demethylase regulating E-cadherin expression. Lower E-cadherin expression is related to a higher level of KDM6A, while E-cadherin is promoted upon treatment with the KDM6A inhibitor GSK-J4 in both high glucose- (HG-) induced HK2 cells and the kidneys from streptozotocin- (STZ-) induced type 1 diabetic mice. However, overexpression or RNA silencing of E-cadherin fails to alter KDM6A expression. We also show that the upregulation of KDM6A is associated with the increased methylation level of the E-cadherin promoter. Then, the target prediction results and a dual-luciferase assay show that hsa-miR-199b-3p is a new miRNA that targets KDM6A. Overexpression of hsa-miR-199b-3p increases E-cadherin expression and prevents EMT through repressing KDM6A expression in HG-induced HK2 cells. In contrast, inhibitor-induced hsa-miR-199b-3p knockdown has opposite effects, as it decreases E-cadherin level and worsens EMT, accompanied by increased levels of KDM6A. Besides, Mir199b-knockout mice without mmu-miR-119b-3p expression exhibit more renal tubule dysfunction and more serious kidney tissue damage upon treatment with STZ. These results demonstrate that hsa-miR-199b-3p improves E-cadherin expression and prevents the progression of DN through targeting KDM6A. miR-199b-3p could be a future biomarker or target for the diagnosis or treatment of DN. Hindawi 2021-06-27 /pmc/articles/PMC8257373/ /pubmed/34257820 http://dx.doi.org/10.1155/2021/8814163 Text en Copyright © 2021 Shoujun Bai et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Bai, Shoujun Xiong, Xiaoyan Tang, Bo Ji, Tingting Li, Xiaoying Qu, Xiaolei Li, Weiliang hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy |
title | hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy |
title_full | hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy |
title_fullStr | hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy |
title_full_unstemmed | hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy |
title_short | hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy |
title_sort | hsa-mir-199b-3p prevents the epithelial-mesenchymal transition and dysfunction of the renal tubule by regulating e-cadherin through targeting kdm6a in diabetic nephropathy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257373/ https://www.ncbi.nlm.nih.gov/pubmed/34257820 http://dx.doi.org/10.1155/2021/8814163 |
work_keys_str_mv | AT baishoujun hsamir199b3ppreventstheepithelialmesenchymaltransitionanddysfunctionoftherenaltubulebyregulatingecadherinthroughtargetingkdm6aindiabeticnephropathy AT xiongxiaoyan hsamir199b3ppreventstheepithelialmesenchymaltransitionanddysfunctionoftherenaltubulebyregulatingecadherinthroughtargetingkdm6aindiabeticnephropathy AT tangbo hsamir199b3ppreventstheepithelialmesenchymaltransitionanddysfunctionoftherenaltubulebyregulatingecadherinthroughtargetingkdm6aindiabeticnephropathy AT jitingting hsamir199b3ppreventstheepithelialmesenchymaltransitionanddysfunctionoftherenaltubulebyregulatingecadherinthroughtargetingkdm6aindiabeticnephropathy AT lixiaoying hsamir199b3ppreventstheepithelialmesenchymaltransitionanddysfunctionoftherenaltubulebyregulatingecadherinthroughtargetingkdm6aindiabeticnephropathy AT quxiaolei hsamir199b3ppreventstheepithelialmesenchymaltransitionanddysfunctionoftherenaltubulebyregulatingecadherinthroughtargetingkdm6aindiabeticnephropathy AT liweiliang hsamir199b3ppreventstheepithelialmesenchymaltransitionanddysfunctionoftherenaltubulebyregulatingecadherinthroughtargetingkdm6aindiabeticnephropathy |